Qualifier English: | CD13 Antigens | ||||||
Qualifier Spanish: |
Antígenos CD13
| ||||||
Qualifier Portuguese: | Antígenos CD13 | ||||||
Qualifier French: | Antigènes CD13 | ||||||
Entry term(s): |
ANPEP Protein Alanine Aminopeptidase Alanyl Aminopeptidase Amino-oligopeptidase Aminooligopeptidase Aminopeptidase M Aminopeptidase N Antigen, CD13 Antigens, CD13 CD13 Antigen Membrane Alanyl Aminopeptidase |
||||||
Tree number(s): |
D08.811.277.656.350.100.160 D08.811.277.656.350.555.100 D08.811.277.656.675.555.100 D23.050.301.264.894.113 D23.101.100.894.113 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D018826 | ||||||
Scope note: | Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 3.4.11.2 | ||||||
Previous Indexing: |
Alanine (1975-1980) Aminopeptidases (1981-1994) Antigens, CD (1991-1994) Antigens, Differentiation (1988) Antigens, Differentiation, Myelomonocytic (1989-1994) |
||||||
Public MeSH Note: | 2018; see ANTIGENS, CD13 1995-2017, CD13 ANTIGEN 1988-94, and ALANINE AMINOPEPTIDASE 1975-94; CD13 ANTIGENS was indexed under ANTIGENS, CD 1991-94; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; and ANTIGENS, DIFFERENTIATION 1988; ALANINE AMINOPEPIDASE was indexed under AMINOPEPTIDASES 1981-94 and under ALANINE 1975-80 |
||||||
History Note: | 2018 (1975) |
||||||
DeCS ID: | 32361 | ||||||
Unique ID: | D018826 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1995/01/01 | ||||||
Date of Entry: | 1994/05/27 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
CD13 Antigens
- Preferred
Aminooligopeptidase
- Narrower
Concept UI |
M0028180 |
Scope note | Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide. |
Preferred term | CD13 Antigens |
Entry term(s) |
ANPEP Protein Alanine Aminopeptidase Alanyl Aminopeptidase Aminopeptidase M Aminopeptidase N Antigen, CD13 Antigens, CD13 CD13 Antigen Membrane Alanyl Aminopeptidase |
Concept UI |
M0114960 |
Scope note | Intestinal aminopeptidase N. |
Preferred term | Aminooligopeptidase |
Entry term(s) |
Amino-oligopeptidase |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey